These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16858149)

  • 1. The evolution of lobular neoplasia.
    Lerwill MF
    Adv Anat Pathol; 2006 Jul; 13(4):157-65. PubMed ID: 16858149
    [No Abstract]   [Full Text] [Related]  

  • 2. Lobular neoplasia: morphology and management.
    Jorns J; Sabel MS; Pang JC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1344-9. PubMed ID: 25268198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast.
    Wood WC
    Semin Oncol; 1996 Aug; 23(4):446-52. PubMed ID: 8757271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mILC-ing the mouse mammary gland: A model for invasive lobular carcinoma.
    Alvarez JV; Perez D; Chodosh LA
    Cancer Cell; 2006 Nov; 10(5):347-9. PubMed ID: 17097555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
    Wells JM; Pipa J; Shin SJ
    Am J Surg Pathol; 2014 Mar; 38(3):434-5. PubMed ID: 24441664
    [No Abstract]   [Full Text] [Related]  

  • 7. Lobular neoplasia.
    King TA; Reis-Filho JS
    Surg Oncol Clin N Am; 2014 Jul; 23(3):487-503. PubMed ID: 24882347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
    Reis-Filho JS; Cancela Paredes J; Milanezi F; Schmitt FC
    Cancer; 2002 Apr; 94(7):2114-5; author reply 2115-6. PubMed ID: 11932917
    [No Abstract]   [Full Text] [Related]  

  • 10. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.
    Simpson PT; Gale T; Fulford LG; Reis-Filho JS; Lakhani SR
    Breast Cancer Res; 2003; 5(5):258-62. PubMed ID: 12927036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular carcinoma in situ with microinvasion.
    Nemoto T; Castillo N; Tsukada Y; Koul A; Eckhert KH; Bauer RL
    J Surg Oncol; 1998 Jan; 67(1):41-6. PubMed ID: 9457256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma.
    Alvarado-Cabrero I; Picón Coronel G; Valencia Cedillo R; Canedo N; Tavassoli FA
    Arch Med Res; 2010 Aug; 41(6):436-41. PubMed ID: 21044747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
    Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC
    Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy.
    Crisi GM; Mandavilli S; Cronin E; Ricci A
    Am J Surg Pathol; 2003 Mar; 27(3):325-33. PubMed ID: 12604888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucinous breast carcinoma with a lobular neoplasia component: a subset with aberrant expression of cell adhesion and polarity molecules and lack of neuroendocrine differentiation.
    Jimbo K; Tsuda H; Yoshida M; Miyagi-Maeshima A; Sasaki-Katsurada Y; Asaga S; Hojo T; Kitagawa Y; Kinoshita T
    Pathol Int; 2014 May; 64(5):217-23. PubMed ID: 24888775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.
    Narendra S; Jenkins SM; Khoor A; Nassar A
    Ann Diagn Pathol; 2015 Apr; 19(2):64-9. PubMed ID: 25682191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular carcinoma in situ and invasive lobular cancer of the breast.
    Cocquyt V; Van Belle S
    Curr Opin Obstet Gynecol; 2005 Feb; 17(1):55-60. PubMed ID: 15711412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast.
    Dabbs DJ; Kaplai M; Chivukula M; Kanbour A; Kanbour-Shakir A; Carter GJ
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):260-6. PubMed ID: 17721269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HER2 in wound-induced breast carcinoma proliferation.
    Tagliabue E; Agresti R; Carcangiu ML; Ghirelli C; Morelli D; Campiglio M; Martel M; Giovanazzi R; Greco M; Balsari A; Ménard S
    Lancet; 2003 Aug; 362(9383):527-33. PubMed ID: 12932384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S; Penzel R; Schirmacher P; Sinn HP
    Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.